Cancer patients are locked in an intensifying struggle with insurers, who sometimes force them to try less expensive drugs before moving to more expensive ones, even against doctors’ wishes.
Now the American Society of Clinical Oncology, or ASCO, is deepening its involvement in the fight, issuing a set of recommendations Tuesday that it hopes insurers will follow as they confront a growing lineup of expensive cancer drugs.
Read the rest…
Read the source article at statnews.com
The post STAT Plus: Instead of ‘fail first,’ try ‘patients first,’ cancer doctors tell insurers appeared first on ePatientFinder®.